{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:59:07Z","timestamp":1791460747642,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1053\/j.jvca.2026.09.021","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:32:27Z","timestamp":1789666347000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Immunoglobulin Administration in Cardiac Surgery, Heart Transplantation and Infective Endocarditis: A Scoping Review"],"prefix":"10.1053","author":[{"given":"Eros","family":"Pilia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Derylo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Guarnieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergej","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Paternoster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Finco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-5980","authenticated-orcid":false,"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Belletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2026.09.021_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1901301","article-title":"Expert consensus recommendations for the prevention and management of immunoglobulin therapy-related adverse reactions in primary and secondary immunodeficiencies: A national Delphi study from the Immunodeficiency Group of the Spanish Society of Immunology","volume":"17","author":"Ferranti-Ramos","year":"2026","journal-title":"Front Immunol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0002","article-title":"Treatment of antibody-mediated rejection in heart transplantation: From empirical combination to multi-target precision intervention","volume":"17","author":"Xu","year":"2026","journal-title":"Front Immunol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0003","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/B978-0-323-90887-0.00006-7","article-title":"Intravenous immunoglobulin use in neurology","author":"Keller","year":"2026"},{"key":"10.1053\/j.jvca.2026.09.021_bib0004","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13054-026-06168-6","article-title":"Sepsis-related immunosuppression: A comprehensive review of current research breakthroughs","volume":"30","author":"Ren","year":"2026","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.09.021_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000048173","article-title":"Safety assessment of intravenous immunoglobulins in pediatric population: A systematic review of adverse events","volume":"105","author":"Altowairqi","year":"2026","journal-title":"Medicine"},{"key":"10.1053\/j.jvca.2026.09.021_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109782","article-title":"Intravenous immunoglobulin in kidney transplantation: Mechanisms of action, clinical applications, adverse effects, and hyperimmune globulin","volume":"256","author":"Hou","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0007","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.3390\/jcm12144645","article-title":"The role of the intravenous IgA and IgM-enriched immunoglobulin preparation in the treatment of sepsis and septic shock","volume":"12","author":"Berlot","year":"2023","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0008","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/jcm10163500","article-title":"Rationale for polyclonal intravenous immunoglobulin adjunctive therapy in COVID-19 patients: Report of a structured multidisciplinary consensus","volume":"10","author":"Coloretti","year":"2021","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0009","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.3390\/jcm14175950","article-title":"A novel scoring system for the administration of an IgM- and IgA-enriched intravenous immunoglobulin preparation: The SORRISO score","volume":"14","author":"Bixio","year":"2025","journal-title":"J Clin Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0010","first-page":"176","article-title":"A position paper on IgM-enriched intravenous immunoglobulin adjunctive therapy in severe acute bacterial infections: The TO-PIRO SCORE proposal","volume":"42","author":"De Rosa","year":"2019","journal-title":"New Microbiol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13613-020-00740-1","article-title":"Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis","volume":"10","author":"Nierhaus","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2026.09.021_bib0012","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13054-024-04964-6","article-title":"Towards personalized medicine: A scoping review of immunotherapy in sepsis","volume":"28","author":"Slim","year":"2024","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2026.09.021_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166821","article-title":"Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs","volume":"14","author":"von Gunten","year":"2023","journal-title":"Front Immunol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0014","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1053-2498(03)00200-6","article-title":"Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients","volume":"23","author":"Vrtovec","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.healun.2004.11.016","article-title":"The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: A randomized single-center study","volume":"24","author":"Yamani","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0016","article-title":"Factors associated with deep sternal wound infection after open-heart surgery in a Danish registry","volume":"31","author":"Gundestrup","year":"2023","journal-title":"Am Heart J Plus"},{"key":"10.1053\/j.jvca.2026.09.021_bib0017","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejcts.2009.09.023","article-title":"Impact of deep sternal wound infection management with vacuum-assisted closure therapy followed by sternal osteosynthesis: A 15-year review of 23,499 sternotomies","volume":"37","author":"Baillot","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0018","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.jvca.2009.02.007","article-title":"Epidemiology of deep sternal wound infection in cardiac surgery","volume":"23","author":"Filsoufi","year":"2009","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.021_bib0019","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.jvca.2015.11.009","article-title":"Sepsis after cardiac surgery: From pathophysiology to management","volume":"30","author":"Paternoster","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.021_bib0020","doi-asserted-by":"crossref","unstructured":"Kollef MH, Sharpless L, Vlasnik J, et al. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest 1997;112:666-75. doi:10.1378\/chest.112.3.666","DOI":"10.1378\/chest.112.3.666"},{"key":"10.1053\/j.jvca.2026.09.021_bib0021","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2334-7-112","article-title":"Superficial and deep sternal wound infection after more than 9000 coronary artery bypass graft (CABG): Incidence, risk factors and mortality","volume":"7","author":"Omran","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.jvca.2026.09.021_bib0022","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s44158-025-00277-4","article-title":"Gene expression kinetics in sepsis after cardiac surgery (SACS): A multicentric prospective observational study","volume":"5","author":"Radice","year":"2025","journal-title":"J Anesth Analg Crit Care"},{"key":"10.1053\/j.jvca.2026.09.021_bib0023","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/110241598750004670","article-title":"Severe sepsis in cardiac surgical patients","volume":"164","author":"Michalopoulos","year":"1998","journal-title":"Eur J Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0024","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/SHK.0000000000001016","article-title":"Selective LPS adsorption using polymyxin B-immobilized fiber cartridges in sepsis patients following cardiac surgery","volume":"49","author":"Yaroustovsky","year":"2018","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2026.09.021_bib0025","first-page":"332","article-title":"Sepsis in the postoperative period of cardiac surgery: Problem description","volume":"94","author":"De Oliveira","year":"2010","journal-title":"Arq Bras Cardiol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0026","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"2013","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2026.09.021_bib0027","doi-asserted-by":"crossref","first-page":"8859","DOI":"10.3390\/ijms26188859","article-title":"Assessing monoclonal and polyclonal antibodies in sepsis and septic shock: A systematic review of efficacy and safety","volume":"26","author":"Goulas","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.jvca.2026.09.021_bib0028","doi-asserted-by":"crossref","first-page":"55","DOI":"10.23736\/S0031-0808.23.04986-8","article-title":"Beyond the Surviving Sepsis Campaign Guidelines: A systematic review of interventions affecting mortality in sepsis","volume":"66","author":"Sartini","year":"2024","journal-title":"Panminerva Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0029","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1053\/j.jvca.2018.11.026","article-title":"A systematic review and international web-based survey of randomized controlled trials in the perioperative and critical care setting: Interventions reducing mortality","volume":"33","author":"Sartini","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.021_bib0030","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1186\/s12967-023-04592-8","article-title":"Efficacy of IVIG therapy for patients with sepsis: A systematic review and meta-analysis","volume":"21","author":"Pan","year":"2023","journal-title":"J Transl Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0031","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/j.jvca.2005.05.003","article-title":"Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery","volume":"19","author":"Buda","year":"2005","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.021_bib0032","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jtcvs.2013.09.051","article-title":"Efficacy of immunomodulation in the treatment of profound thrombocytopenia after adult cardiac surgery","volume":"147","author":"Rankin","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0033","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtcvs.2011.04.042","article-title":"Management of immune dysfunction after adult cardiac surgery","volume":"142","author":"Rankin","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0034","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032979","article-title":"Management of cardiovascular surgery in patients with systemic lupus erythematosus including thromboembolism and multiple organ failure prevention: A retrospective observational study","volume":"102","author":"Yamamoto","year":"2023","journal-title":"Medicine"},{"key":"10.1053\/j.jvca.2026.09.021_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0036","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2026.09.021_bib0037","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1128\/AAC.39.7.1643","article-title":"Prospective randomized trial of efficacy of ganciclovir versus that of anti-cytomegalovirus (CMV) immunoglobulin to prevent CMV disease in CMV-seropositive heart transplant recipients treated with OKT3","volume":"39","author":"Aguado","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.jvca.2026.09.021_bib0038","first-page":"544","article-title":"IgM-enriched immunoglobulin preparation for immunoprophylaxis in cardiac surgery","volume":"7","author":"Friedrich","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1053\/j.jvca.2026.09.021_bib0039","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1378\/chest.111.2.419","article-title":"Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis","volume":"111","author":"Pilz","year":"1997","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.09.021_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00003246-199907000-00011","article-title":"Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A- and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery","volume":"27","author":"Kress","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0041","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/11024159950188501","article-title":"A multicentre randomised placebo-controlled double-blind study on adjuvant treatment of mediastinitis with immunoglobulins (Pentaglobin\u00ae) after cardiac surgery (ATMI): Outline and preliminary study protocol for discussion","volume":"164","author":"Marggraf","year":"1999","journal-title":"Eur J Surgery Suppl"},{"key":"10.1053\/j.jvca.2026.09.021_bib0042","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.CCM.0B013E3181611F62F","article-title":"Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome\u2014the ESSICS study","volume":"36","author":"Werdan","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0043","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0044","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/CCM.0000000000007089","article-title":"Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2026","volume":"54","author":"Prescott","year":"2026","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2015.01.022","article-title":"Intravenous immunoglobulin in critically ill adults: When and what is the evidence?","volume":"30","author":"Wang","year":"2015","journal-title":"J Crit Care"},{"key":"10.1053\/j.jvca.2026.09.021_bib0046","first-page":"559","article-title":"Intravenous immunoglobulin in septic shock: Review of the mechanisms of action and meta-analysis of the clinical effectiveness","volume":"82","author":"Busani","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0047","doi-asserted-by":"crossref","first-page":"4","DOI":"10.22514\/sv.2025.092","article-title":"Approach to the transplanted patient in acute care: A comprehensive update","volume":"21","author":"Akman","year":"2025","journal-title":"Signa Vitae"},{"issue":"4","key":"10.1053\/j.jvca.2026.09.021_bib0048","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1399-0012.2006.00509.x","article-title":"Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin","volume":"20","author":"Leech","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0049","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/ajt.14876","article-title":"Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study","volume":"18","author":"Webber","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0050","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.healun.2023.05.001","article-title":"Three year post heart transplant outcomes of desensitized durable mechanical circulatory support patients","volume":"42","author":"Youn","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0051","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.intimp.2008.09.013","article-title":"Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation","volume":"9","author":"Sarmiento","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0052","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00007890-200111270-00012","article-title":"Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: A comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone","volume":"72","author":"Valantine","year":"2001","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2026.09.021_bib0053","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2010.02.060","article-title":"Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients","volume":"56","author":"Moulik","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2026.09.021_bib0054","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1378\/chest.97.2.396","article-title":"Cytomegalovirus seronegative heart transplant recipients: Prophylactic use of anti-CMV immunoglobulin","volume":"97","author":"Metselaar","year":"1990","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2026.09.021_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2026.09.021_bib0056","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/TP.0b013e318244f7b8","article-title":"Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody","volume":"93","author":"Hodges","year":"2012","journal-title":"Transplantation"},{"key":"10.1053\/j.jvca.2026.09.021_bib0057","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.healun.2015.03.002","article-title":"Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy","volume":"34","author":"Coutance","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0058","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.healun.2016.06.014","article-title":"A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes","volume":"35","author":"Thrush","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1053\/j.jvca.2026.09.021_bib0059","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1056\/NEJM199207233270404","article-title":"Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection","volume":"327","author":"Cometta","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0060","first-page":"63","article-title":"Immunoprophylaxis in \u201cseptic risk\u201d patients undergoing surgery for gastrointestinal cancer. Results of a randomized, multicenter clinical trial","volume":"78","author":"Gipponi","year":"1993","journal-title":"Int Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2011.09.011","article-title":"Clinical implications and molecular mechanisms of immunoparalysis after cardiopulmonary bypass","volume":"143","author":"Cornell","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2026.09.021_bib0062","first-page":"2693","article-title":"Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study","volume":"35","author":"Werdan","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0063","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1053\/j.jvca.2025.01.037","article-title":"Pancreatic stone protein as sepsis biomarker in patients requiring mechanical circulatory support: A pilot observational study","volume":"39","author":"Belletti","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2026.09.021_bib0064","first-page":"70","article-title":"Presepsin as a predictor of septic shock and mortality in patients with urinary tract infection according to the Sepsis-3 definitions","volume":"20","author":"Yang","year":"2024","journal-title":"Signa Vitae"},{"key":"10.1053\/j.jvca.2026.09.021_bib0065","doi-asserted-by":"crossref","unstructured":"Domizi R, Damiani E, Carsetti A, et al. Prognostic value and organ-specific correlations of admission MR-proADM in critically ill patients: A retrospective exploratory study [published online July 9, 2026]. J Anesth Analg Crit Care. doi:10.1186\/S44158-026-00428-1","DOI":"10.1186\/s44158-026-00428-1"},{"key":"10.1053\/j.jvca.2026.09.021_bib0066","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14225","article-title":"Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis","volume":"54","author":"Valeriani","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.jvca.2026.09.021_bib0067","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jama.2025.24175","article-title":"Precision immunotherapy to improve sepsis outcomes: The ImmunoSep randomized clinical trial","volume":"335","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2026.09.021_bib0068","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067251","article-title":"ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: Study protocol","volume":"12","author":"Kotsaki","year":"2022","journal-title":"BMJ Open"},{"key":"10.1053\/j.jvca.2026.09.021_bib0069","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00134-026-08323-7","article-title":"Endotype trajectories: Better understanding for better sepsis management","volume":"52","author":"Giamarellos-Bourboulis","year":"2026","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2026.09.021_bib0070","doi-asserted-by":"crossref","unstructured":"Snow TAC, Ryckaert F, Hass I, Pan H, Elkhodair S, Singer M, Brealey D, Arulkumaran N. University College London Hospitals Critical Care Research Team. Immune signatures of sepsis from mild infection to critical illness - a prospective observational study. Front Immunol. 2026;16: 1715812. https:\/\/doi.org\/10.3389\/fimmu.2025.1715812.","DOI":"10.3389\/fimmu.2025.1715812"},{"key":"10.1053\/j.jvca.2026.09.021_bib0071","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-2600(25)00429-1","article-title":"Quantifying immune dysregulation in pneumonia and sepsis with a parsimonious machine-learning model: A multicohort analysis across care settings and reanalysis of a hydrocortisone randomised controlled trial","volume":"14","author":"Michels","year":"2026","journal-title":"Lancet Respir Med"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026009262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077026009262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:34:40Z","timestamp":1791459280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077026009262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":71,"alternative-id":["S1053077026009262"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2026.09.021","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Immunoglobulin Administration in Cardiac Surgery, Heart Transplantation and Infective Endocarditis: A Scoping Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2026.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}